Daiwa Securities Group Inc. lowered its stake in shares of Aetna Inc (NYSE:AET) by 75.0% in the fourth quarter, Holdings Channel reports. The firm owned 11,468 shares of the company’s stock after selling 34,340 shares during the period. Daiwa Securities Group Inc.’s holdings in Aetna were worth $2,069,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Janus Henderson Group PLC boosted its stake in Aetna by 1.8% during the 3rd quarter. Janus Henderson Group PLC now owns 4,407,172 shares of the company’s stock valued at $700,784,000 after purchasing an additional 78,272 shares during the last quarter. Neuberger Berman Group LLC boosted its stake in Aetna by 5.9% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,487,570 shares of the company’s stock valued at $236,538,000 after purchasing an additional 82,540 shares during the last quarter. Orbimed Advisors LLC boosted its stake in Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock valued at $222,057,000 after purchasing an additional 508,600 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Aetna by 4.2% during the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock valued at $217,144,000 after purchasing an additional 54,928 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its stake in Aetna by 2.6% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock valued at $222,868,000 after purchasing an additional 30,799 shares during the last quarter. Institutional investors and hedge funds own 87.10% of the company’s stock.

Shares of Aetna Inc (NYSE AET) opened at $176.77 on Thursday. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. The company has a market cap of $58,365.78, a P/E ratio of 30.74, a P/E/G ratio of 1.45 and a beta of 0.60. Aetna Inc has a 1-year low of $124.83 and a 1-year high of $194.40.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. The company had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. Aetna’s revenue was down 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.08 EPS. analysts expect that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were issued a $0.50 dividend. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is presently 34.78%.

AET has been the topic of several recent analyst reports. Citigroup lifted their target price on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research report on Thursday, November 2nd. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Deutsche Bank raised shares of Aetna from a “hold” rating to a “buy” rating and lifted their target price for the stock from $195.00 to $212.00 in a research report on Monday, January 22nd. Piper Jaffray Companies reissued a “buy” rating and set a $212.00 target price on shares of Aetna in a research report on Tuesday, January 30th. Finally, Cowen reissued a “buy” rating and set a $212.00 target price on shares of Aetna in a research report on Tuesday, January 30th. Ten investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Aetna currently has an average rating of “Buy” and a consensus price target of $185.94.

TRADEMARK VIOLATION WARNING: This piece of content was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://theolympiareport.com/2018/02/15/daiwa-securities-group-inc-has-2-07-million-holdings-in-aetna-inc-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.